Brookside Capital: Funding, Team & Investors

Brookside Capital LLC provides business development advisory services to technology companies focused on clean technology, agriculture, water, and renewable energy. The firm guides startups from initial concept to profitable commercialization, offering expert advising, thorough evaluation, and strategic investment. It transforms nascent innovations into market-ready solutions by leveraging specialized regional expertise.

David A. Forsee founded Brookside Capital, identifying a significant need for experienced guidance among innovative technology companies emerging from the Midwest and Rocky Mountain regions. A Harvard Business School MBA with prior executive experience in technology venture-backed companies, Forsee established the firm to empower entrepreneurs, helping them translate groundbreaking ideas into viable, flourishing businesses.

The firm primarily serves technology entrepreneurs and investors developing ventures within its specified environmental and agricultural domains. Brookside Capital bridges the gap between scientific innovation and market success, providing crucial strategic support for launch and sustained expansion. Its vision is to foster an ecosystem where technological inspiration consistently translates into robust, profitable enterprises that drive sustainable development.

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 14, 2016	Anaplan	$90.0M Other Equity	Sandesh Patnam	Coatue, DFJ Growth, Founders Circle Capital, Granite Ventures, Harmony Partners, Meritech Capital Partners, Salesforce, Sands Capital, Shasta Ventures
Jan 1, 2016	Anaplan	$90.0M Series E	Premji Invest	Benchmark, Catapult Capital, Crosslink Capital, DFJ, Founders Circle Capital, Karim Faris, Inventus Capital Partners, LAUNCH, Lead Edge Capital, Meritech Capital Partners, NewView Capital, Scale Venture Partners, Shasta Ventures, Streamlined Ventures, Touchdown Ventures, True Ventures, Uncorrelated Ventures, Unusual Ventures, Baillie Gifford, Coatue, DFJ Growth, Granite Ventures, Harmony Partners, Salesforce, Sands Capital
Sep 1, 2015	SevOne	$47.0M Series C	Benjamin NYE, Will Muggia	Flybridge, Osage University Partners, Venture Guides, HarbourVest Partners, Osage Venture Partners, VT Technology Ventures
Jul 23, 2015	Giosis	$82.1M Series A	Alan Chan Heng Loon	EBay, OAK Investment Partners, Saban Capital Group, UVM 2 Venture Investments
Jul 1, 2015	Translate Bio	$64.0M Series B	Baupost Group, Joshua Resnick	Atlas Venture, Dcvc (data Collective), Leerink Partners, Monsanto, MS Ventures, Omega Funds, Partners Innovation Fund, Rock Springs Capital, SR ONE
May 1, 2015	MuleSoft	$130.0M Series G	John Somorjai	Stuart Peterson, Ballistic Ventures, Battery Ventures, Benchmark, Canvas Ventures, Chicago Ventures, Comcast Ventures, Decibel Partners, Dell Technologies Capital, Felicis Ventures, Flex Capital, Flybridge, HWVP (Hummer Winblad Venture Partners), Insight Partners, InterWest, Lightspeed Venture Partners, Maveron, Meritech Capital Partners, NEO, NewView Capital, OrbiMed, Sapphire Ventures, Sequoia Capital, StageOne Ventures, Union Square Ventures, Westlake Village BioPartners, Wildcat Ventures, Xstarpartners, Zetta Venture Partners, Farzad Nazem, Hadi Partovi, JED Stremel, Mark Goines, Scott Banister, William Watkins, Adage Capital Management, BAY Partners, Cisco Investments, Hummer Winblad Venture Partners, Morgenthaler Ventures, NEW Enterprise Associates, Sands Capital, ServiceNow Ventures
May 1, 2015	REGENXBIO	$71.0M Series D	Venrock, Vivo Capital, Brookside Capital	ARCH Venture Partners, Canaan Partners, Cormorant Asset Management, Deerfield Management, Foresite Capital, F Prime Capital, Janus Henderson Investors, Jennison Associates, Perceptive Advisors, QVT, RTW Investments, Sectoral Asset Management, Tourbillon Global Ventures
Jan 1, 2015	REGENXBIO	$30.0M Series C	Venrock, Brookside Capital	ARCH Venture Partners, Deerfield Management, Foxkiser, F Prime Capital
May 27, 2014	Spark Therapeutics, Inc.	$72.8M Series B	Anand Mehra	Katherine High, Deerfield Management, Rock Springs Capital, T. Rowe Price Associates, Wellington Management
May 1, 2014	Anaplan	$100.0M Series D	DFJ	Benchmark, Crosslink Capital, Karim Faris, Inventus Capital Partners, LAUNCH, Lead Edge Capital, Meritech Capital Partners, NewView Capital, Scale Venture Partners, Shasta Ventures, Streamlined Ventures, True Ventures, Uncorrelated Ventures, Unusual Ventures, Coatue, Granite Ventures, Salesforce Ventures, Sands Capital, Workday
Dec 1, 2013	Larimar Therapeutics	$45.0M Series E	—	Creacion Ventures, MPM Capital, RED Tree Venture Capital, Alta Partners, RA Capital Management, Venrock
Jul 1, 2013	Dicerna Pharmaceuticals	$60.0M Series C	Peter Kolchinsky	Domain Associates, Morgenthaler Ventures, Piva Capital, TED Driscoll, Abingworth, Deerfield Management, Omega Funds, Oxford Bioscience Partners, Skyline Ventures, SR ONE

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 14, 2016	Anaplan	$90.0M Other Equity	Sandesh Patnam	Coatue, DFJ Growth, Founders Circle Capital, Granite Ventures, Harmony Partners, Meritech Capital Partners, Salesforce, Sands Capital, Shasta Ventures
Jan 1, 2016	Anaplan	$90.0M Series E	Premji Invest	Benchmark, Catapult Capital, Crosslink Capital, DFJ, Founders Circle Capital, Karim Faris, Inventus Capital Partners, LAUNCH, Lead Edge Capital, Meritech Capital Partners, NewView Capital, Scale Venture Partners, Shasta Ventures, Streamlined Ventures, Touchdown Ventures, True Ventures, Uncorrelated Ventures, Unusual Ventures, Baillie Gifford, Coatue, DFJ Growth, Granite Ventures, Harmony Partners, Salesforce, Sands Capital
Sep 1, 2015	SevOne	$47.0M Series C	Benjamin NYE, Will Muggia	Flybridge, Osage University Partners, Venture Guides, HarbourVest Partners, Osage Venture Partners, VT Technology Ventures
Jul 23, 2015	Giosis	$82.1M Series A	Alan Chan Heng Loon	EBay, OAK Investment Partners, Saban Capital Group, UVM 2 Venture Investments
Jul 1, 2015	Translate Bio	$64.0M Series B	Baupost Group, Joshua Resnick	Atlas Venture, Dcvc (data Collective), Leerink Partners, Monsanto, MS Ventures, Omega Funds, Partners Innovation Fund, Rock Springs Capital, SR ONE
May 1, 2015	MuleSoft	$130.0M Series G	John Somorjai	Stuart Peterson, Ballistic Ventures, Battery Ventures, Benchmark, Canvas Ventures, Chicago Ventures, Comcast Ventures, Decibel Partners, Dell Technologies Capital, Felicis Ventures, Flex Capital, Flybridge, HWVP (Hummer Winblad Venture Partners), Insight Partners, InterWest, Lightspeed Venture Partners, Maveron, Meritech Capital Partners, NEO, NewView Capital, OrbiMed, Sapphire Ventures, Sequoia Capital, StageOne Ventures, Union Square Ventures, Westlake Village BioPartners, Wildcat Ventures, Xstarpartners, Zetta Venture Partners, Farzad Nazem, Hadi Partovi, JED Stremel, Mark Goines, Scott Banister, William Watkins, Adage Capital Management, BAY Partners, Cisco Investments, Hummer Winblad Venture Partners, Morgenthaler Ventures, NEW Enterprise Associates, Sands Capital, ServiceNow Ventures
May 1, 2015	REGENXBIO	$71.0M Series D	Venrock, Vivo Capital, Brookside Capital	ARCH Venture Partners, Canaan Partners, Cormorant Asset Management, Deerfield Management, Foresite Capital, F Prime Capital, Janus Henderson Investors, Jennison Associates, Perceptive Advisors, QVT, RTW Investments, Sectoral Asset Management, Tourbillon Global Ventures
Jan 1, 2015	REGENXBIO	$30.0M Series C	Venrock, Brookside Capital	ARCH Venture Partners, Deerfield Management, Foxkiser, F Prime Capital
May 27, 2014	Spark Therapeutics, Inc.	$72.8M Series B	Anand Mehra	Katherine High, Deerfield Management, Rock Springs Capital, T. Rowe Price Associates, Wellington Management
May 1, 2014	Anaplan	$100.0M Series D	DFJ	Benchmark, Crosslink Capital, Karim Faris, Inventus Capital Partners, LAUNCH, Lead Edge Capital, Meritech Capital Partners, NewView Capital, Scale Venture Partners, Shasta Ventures, Streamlined Ventures, True Ventures, Uncorrelated Ventures, Unusual Ventures, Coatue, Granite Ventures, Salesforce Ventures, Sands Capital, Workday
Dec 1, 2013	Larimar Therapeutics	$45.0M Series E	—	Creacion Ventures, MPM Capital, RED Tree Venture Capital, Alta Partners, RA Capital Management, Venrock
Jul 1, 2013	Dicerna Pharmaceuticals	$60.0M Series C	Peter Kolchinsky	Domain Associates, Morgenthaler Ventures, Piva Capital, TED Driscoll, Abingworth, Deerfield Management, Omega Funds, Oxford Bioscience Partners, Skyline Ventures, SR ONE

Brookside Capital

Subscribe, Save or Share

About

Investment Activity

Investments Made

Financial History

Deep Dive

Sources

Deep Dive

Sources

Investment Activity

Investments Made